Russell MW - Search Results

1

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.

Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Gupta K, et al. Among authors: russell mw. Cancer Treat Rev. 2008 May;34(3):193-205. doi: 10.1016/j.ctrv.2007.12.001. Epub 2008 Mar 4. Cancer Treat Rev. 2008. PMID: 18313224 Review.

2

The economic burden of metastatic breast cancer: a systematic review of literature from developed countries.

Foster TS, Miller JD, Boye ME, Blieden MB, Gidwani R, Russell MW. Foster TS, et al. Among authors: russell mw. Cancer Treat Rev. 2011 Oct;37(6):405-15. doi: 10.1016/j.ctrv.2010.12.008. Epub 2011 Apr 8. Cancer Treat Rev. 2011. PMID: 21477928 Review.

3

Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature.

Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J. Foster TS, et al. Among authors: russell mw. COPD. 2006 Dec;3(4):211-8. doi: 10.1080/15412550601009396. COPD. 2006. PMID: 17361502 Review.

4

Economic burden of follicular non-Hodgkin's lymphoma.

Foster T, Miller JD, Boye ME, Russell MW. Foster T, et al. Among authors: russell mw. Pharmacoeconomics. 2009;27(8):657-79. doi: 10.2165/11314820-000000000-00000. Pharmacoeconomics. 2009. PMID: 19712009 Review.

5

Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis.

Singh G, Miller JD, Huse DM, Pettitt D, D'Agostino RB, Russell MW. Singh G, et al. Among authors: russell mw. J Rheumatol. 2003 Apr;30(4):714-9. J Rheumatol. 2003. PMID: 12672188

6

Cost-effectiveness analysis of interferon beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosis.

Caloyeras JP, Zhang B, Wang C, Eriksson M, Fredrikson S, Beckmann K, Knappertz V, Pohl C, Hartung HP, Shah D, Miller JD, Sandbrink R, Lanius V, Gondek K, Russell MW. Caloyeras JP, et al. Among authors: russell mw. Clin Ther. 2012 May;34(5):1132-44. doi: 10.1016/j.clinthera.2012.03.004. Epub 2012 Apr 27. Clin Ther. 2012. PMID: 22541587

7

Current challenges in health economic modeling of cancer therapies: a research inquiry.

Miller JD, Foley KA, Russell MW. Miller JD, et al. Among authors: russell mw. Am Health Drug Benefits. 2014 May;7(3):153-62. Am Health Drug Benefits. 2014. PMID: 24991399 Free PMC article. Review.

8

Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data.

Miller JD, Foster T, Boulanger L, Chace M, Russell MW, Marton JP, Menzin J. Miller JD, et al. Among authors: russell mw. COPD. 2005 Sep;2(3):311-8. doi: 10.1080/15412550500218221. COPD. 2005. PMID: 17146996

9

Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey.

Singh G, Miller JD, Lee FH, Pettitt D, Russell MW. Singh G, et al. Among authors: russell mw. Am J Manag Care. 2002 Oct;8(15 Suppl):S383-91. Am J Manag Care. 2002. PMID: 12416788 Free article.

10

Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden.

Gadler F, Ding Y, Verin N, Bergius M, Miller JD, Lenhart GM, Russell MW. Gadler F, et al. Among authors: russell mw. Clinicoecon Outcomes Res. 2016 Oct 31;8:657-666. doi: 10.2147/CEOR.S114921. eCollection 2016. Clinicoecon Outcomes Res. 2016. PMID: 27826203 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters